ヒトパピローマウイルス感染症(Human Papillomavirus Infections)：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Human Papillomavirus Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Human Papillomavirus Infections 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Human Papillomavirus Infections Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Human Papillomavirus Infections 33
Nov 18, 2014: Researchers Pioneer New Approach To Treating HPV-Related Cervical Cancer 33
Nov 13, 2014: Genticel completes ProCervix Phase II study enrollment ahead of schedule 34
Nov 04, 2014: Cevira data published in American Journal of Obstetrics & Gynecology 34
Oct 30, 2014: Genexine’s HPV Therapeutic Vaccine Achieved High Efficacy in Phase I Cervical Dysplasia Trial 35
Oct 10, 2014: Results of the Cevira Phase 2b presented at DGGG 35
Oct 08, 2014: Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vaccine 36
Sep 22, 2014: Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Merck & Co., Inc. 38
Clinical Trial Overview of Merck & Co., Inc. 38
GlaxoSmithKline plc 43
Clinical Trial Overview of GlaxoSmithKline plc 43
Medicis Pharmaceutical Corporation 48
Clinical Trial Overview of Medicis Pharmaceutical Corporation 48
BioMAS Ltd. 49
Clinical Trial Overview of BioMAS Ltd. 49
AstraZeneca PLC 50
Clinical Trial Overview of AstraZeneca PLC 50
Novartis AG 51
Clinical Trial Overview of Novartis AG 51
MediGene AG 52
Clinical Trial Overview of MediGene AG 52
Meda AB 53
Clinical Trial Overview of Meda AB 53
Genticel S.A. 54
Clinical Trial Overview of Genticel S.A. 54
G&E Herbal Biotechnology Co., Ltd. 55
Clinical Trial Overview of G&E Herbal Biotechnology Co., Ltd. 55
Clinical Trial Overview of Top Institutes / Government 56
The National Institute of Allergy and Infectious Diseases 56
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 56
National Cancer Institute 57
Clinical Trial Overview of National Cancer Institute 57
Johns Hopkins University 58
Clinical Trial Overview of Johns Hopkins University 58
University of Pittsburgh 59
Clinical Trial Overview of University of Pittsburgh 59
The University of Hong Kong 60
Clinical Trial Overview of The University of Hong Kong 60
Leiden University Medical Center 61
Clinical Trial Overview of Leiden University Medical Center 61
Medical University of Vienna 62
Clinical Trial Overview of Medical University of Vienna 62
AIDS Malignancy Clinical Trials Consortium 63
Clinical Trial Overview of AIDS Malignancy Clinical Trials Consortium 63
The Alfred Hospital 64
Clinical Trial Overview of The Alfred Hospital 64
The University of Sydney 65
Clinical Trial Overview of The University of Sydney 65
Five Key Clinical Profiles 66
Appendix 99
Abbreviations 99
Definitions 99
Research Methodology 100
Secondary Research 100
About GlobalData 101
Contact Us 101
Disclaimer 101
Source 101